CLINICAL_TRIALS trial_result · 2012-02-01

Clinical Trial Update: Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

This entry reports the completion of Crohn's disease study P03288 for Remicade (infliximab), with results posted in February 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn's Disease | Status: COMPLETED | Results posted: 2012-02-01